Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gradually Enlarging Crazy-paving Appearance.
Kunimasa K, Tachihara M, Terashita T, Nishimura Y. Kunimasa K, et al. Among authors: tachihara m. Intern Med. 2015;54(21):2791-2. doi: 10.2169/internalmedicine.54.5127. Epub 2015 Nov 1. Intern Med. 2015. PMID: 26521917 Free article. No abstract available.
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
Kunimasa K, Nagano T, Shimono Y, Dokuni R, Kiriu T, Tokunaga S, Tamura D, Yamamoto M, Tachihara M, Kobayashi K, Satouchi M, Nishimura Y. Kunimasa K, et al. Among authors: tachihara m. Cancer Sci. 2017 Jul;108(7):1368-1377. doi: 10.1111/cas.13266. Epub 2017 Jun 19. Cancer Sci. 2017. PMID: 28445002 Free PMC article.
Amphiregulin as a Novel Resistance Factor for Amrubicin in Lung Cancer Cells.
Tokunaga S, Nagano T, Kobayashi K, Katsurada M, Nakata K, Yamamoto M, Tachihara M, Kamiryo H, Yokozaki H, Nishimura Y. Tokunaga S, et al. Among authors: tachihara m. Anticancer Res. 2017 May;37(5):2225-2231. doi: 10.21873/anticanres.11558. Anticancer Res. 2017. PMID: 28476786
115 results